References
Ryan C, Korman NJ, Gelfand JM, et al. Research gaps in psoriasis: opportunities for future studies. J Am Acad Dermatol 2014; 70: 146–p67.
Dowlatshahi EA, Wakkee M, Arends LR, et al. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol 2014; 134: 1542–p51.
Abbott R, Whear R, Nikolaou V, et al. Tumour necrosis factor-alpha inhibitor therapy in chronic physical illness: a systematic review and meta-analysis of the effect on depression and anxiety. J Psychosom Res 2015; 79: 175–p84.
Fleming P, Roubille C, Richer V, et al. Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review. J Eur Acad Dermatol Venereol 2015; 29: 1063–p70.
Griffiths CEM, Fava M, Miller AH, et al. Impact of ixekizumab treatment on depressive symptoms and systemic inflammation in patients with moderate-to-severe psoriasis: an integrated analysis of three Phase 3 clinical studies. Psychother Psychosom 2017; 86: 260–p7.
Lamoureux BE, Linardatos E, Fresco DM, et al. Using the QIDS-SR16 to identify major depressive disorder in primary care medical patients. Behav Ther 2010; 41: 423–p31.
Lowe B, Decker O, Muller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 2008; 46: 266–p74.
Ware J Jr., Kosinski M, Keller SD. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–p33.
Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353–p65.
Chen Y, Xin T, Cheng AS. Evaluating the effectiveness of psychological and/or educational interventions in psoriasis: a narrative review. J Dermatol 2014; 41: 775–p8.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tengattini, V., Foschi, L., Rucci, P. et al. Effectiveness of psychological intervention in psoriatic patients relative to standard care. Eur J Dermatol 29, 231–233 (2019). https://doi.org/10.1684/ejd.2019.3515
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2019.3515